Pain Management: A Global Strategic Business Report
San Jose, CA (PRWEB) March 11, 2008
Widespread availability of generic drugs, emergence of pain management clinics, and the advent of new drugs have accelerated the pace of growth in the market. Dynamics will also be impacted by patent expiry of top NSAIDs drugs. Pain Therapeutics market persists with regular developments and discoveries of new drugs addressing pain related health ailment issue. Moreover higher demand for more efficient medical devices for pain treatment and drugs continue to drive the market for pain management.
Healthcare reforms and reimbursement structure continue to shape demand for services, drugs and devices. The market is primarily driven by factors such as growing consumer demand, increase in people aged over 65, new surgical procedures, and product introductions.
United States is the largest market worldwide, worth an estimated US$14.5 billion in 2007 as stated by Global Industry Analysts, Inc. Collectively, the US, Europe and Asia account for over 85 percent of the global pain management market. Global demand for pain management devices is fueled by availability of highly efficient medical devices that do not cause any side effects. Further, the medical devices are well documented for treating pains that do not respond to drugs. Pain management devices market is valued at US$2.0 billion in 2007.
Dynamics of the pain management pharmaceuticals market witnessed significant changes in recent years. The failure of several drugs, considered initially as promisingly curative including recent unsuccessful COX-2 inhibitors, prompted manufacturers and researchers to undertake more research programs. Drug delivery firms and larger pharmaceutical companies are undertaking partnerships by launching old therapies in new formulations. Partnerships among drug delivery firms and leading pharma companies are expected to produce tamper- and abuse-resistant novel drug innovations.
Market participants include AstraZeneca PLC, Eli Lilly and Company, Glaxo Smithkline Plc, Johnson & Johnson, Merck & Co., Inc, Novartis Pharmaceuticals Corporation, Pfizer Inc., Purdue Pharma, Sanofi Aventis, Wyeth.
"Pain Management: A Global Strategic Business Report" published by Global Industry Analysts, Inc., provides a comprehensive review of market trends, drivers, product profile, players, competition, regulatory environment, recent developments, mergers, acquisitions, and other strategic industry activities. Analysis is presented for major geographic markets such as United States, Japan, France, Germany, the UK, Italy, Spain, Asia, Latin America and rest of world. Analytics are provided in terms of product segments including Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services. The study also presents historic data for an insight into market evolution over the past fifteen years.
For more details about this research report, please visit http://www.strategyr.com/Pain_Management_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Web Site http://www.StrategyR.com